Metastatic melanoma to regional lymph nodes

In Vivo

Volumn 14, Issue 1, 2000, Pages 213-220

  Reintgen, Douglas ^a   Li, Weiguo ^a   Stall, Alex ^a   Linn, Jeffrey ^a   Shivers, Steven ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

Lymphatic mapping; Melanoma; Regional lymph nodes; Staging

Indexed keywords

MESSENGER RNA; MONOPHENOL MONOOXYGENASE; RECOMBINANT ALPHA2B INTERFERON;

CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; HEALTH CARE COST; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH FLOW; LYMPH NODE BIOPSY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHADENECTOMY; LYMPHATIC DRAINAGE; LYMPHOSCINTIGRAPHY; MELANOMA; MORTALITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; UNITED STATES;

EID: 0034076036     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (33)

1. Parker SL, Tong T, Bolden S, Wingo PA. Cancer Statistics, 1996, CA: A Cancer Journal For Clinicians. 46: 5-28, 1996.
2. Morton DL, Wen DR, Wong JH, Economou JS, Cagel LA, Storm KS, Foshag LJ, Cochran AJ. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 127: 392-399, 1992
3. Morton DL, Wen DR, Cochran AJ. Management of early-stage melanoma by intraoperative lymphatic mapping and selective lymphadenectomy or "watch and wait." Surg Oncology Clin North Amer 1: 247-259, 1992
4. Reintgen DS, Cruse CW, Berman C, Ross M, Rappaport D, Glass F, Fenske N, Messina J, Reintgen DS. An orderly progression of melanoma nodal metastases. Ann Surg 220: 759-767, 1994
5. Ross MI, Reintgen DS, Balch CM. Selective Lymphadenectomy: The Emerging Role of Lymphatic Mapping and Sentinel Node Biopsy in the management of early stage melanoma. Seminars Oncol 9: 219-223, 1993.
6. Wang X, Heller R, VanVoorhis N et al: Detection of submicroscopic metastases with polymerase chain reaction in patients with malignant melanoma. Ann Surg 220: 768-774, 1994.
7. Reintgen DS, Albertini J, Berman C et al: Accurate nodal staging of malignant melanoma. Cancer Control. Journal of the Moffitt Cancer Center 2: 405-414, 1995.
8. Veronesi U, Adamus J, Bandiera DC et al: Inefficacy of immediate node dissection in stage I melanoma of the limbs. N Engl J Med 297: 627, 1977.
9. Sim FH, Taylor WF, Pritchard DJ, et al: Lymphadenectomy in the management of stage I malignant melanoma: A prospective randomized study. Mayo Clin Proc 61: 697, 1986.
10. Balch CM, Milton GW, Cascinelli N, Milton GW, Sim FH: Elective node dissection: Pros and cons. In: Balch CM, Houghton AN, Milton GW, Sober A, Soong S-j (eds): Cutaneous Melanoma, 2nd edition, p 345, Philadelphia, J B Lippincott, 1992.
11. Milton GW, Shaw HM, McCarthy WH, et al: Prophylactic lymph node dissection in clinical stage I cutaneous malignant melanoma: Results of surgical treatment in 1319 patients. Br J Surg 69: 108, 1982
12. Reintgen DS, Cox EB, McCarty KM Jr, et al: Efficacy of elective lymph node dissection in patients with intermediate thickness primary melanoma. Ann Surg 198: 379, 1983
13. Breslow A: Thickness, cross-sectional areas and depth of melanoma in the prognosis of cutaneous melanoma. Ann Surg 72: 902, 1970
14. Balch CM, Soong S-j, Shaw HM, Urist MM, McCarthy WH: An analysis of prognostic factors in 8500 patients with cutaneous melanoma. In: Balch CM, Houghton AN, Milton GW, Sober A, Soong S-j (eds. Cutaneous Melanoma, 2nd edition, p 165. Philadelphia, J B Lippincott, 1992
15. Balch CM, Soong S-j, Milton GW, et al: A comparison of prognostic factors and surgical results in 1,786 patients with localized (stage I) melanoma treated in Alabama, USA, and New South Wales, Australia. Ann Surg 196: 677, 1982
16. Schneebaum S, Briele HA, Walker MJ, et al: Cutaneous thick melanoma: Prognosis and treatment. Arch Surg 122: 707-711, 1987
17. Norman J, Cruse CW, Espinos C et al: Redefinition of cutaneous lymphatic drainage with the use of lymphoscintigraphy for malignant melanoma. Am J Surg 162: 432-437, 1991
18. McCarthy WH, Uren RF, Thompson J. How lymphoscintigraphy aids melanoma treatment. The Skin Cancer Foundation Journal 14: 32-35.
19. Norman J, Wells K, Kearney R, Cruse CW, Berman C, Reintgen DS. Identification of lymphatic drainage patterns in patients with cutaneous melanoma. Sem Surg Oncol 9: 224-227, 1993.
20. Veronesi U, Adams J, Bandiera DC, et al: Delayed regional lymph node dissection in stage I melanoma of the skin of the lower extremities. Cancer 49: 2420, 1982
21. Balch C et al: A prospective randomized surgical trial of 742 melanoma patients comparing the efficacy of elective node dissection (immediate) versus observation. Results of the Intergroup Surgical Trial. Ann Surg 224: 255-266, 1996.
22. Balch CM: The role of elective lymph node dissection in melanoma: Rationale, results and controversies. J Clin Oncol 6: 163, and 6: 392, 1988.
23. Balch CM: The role of elective lymph node dissection in melanoma: Rationale, results and controversies. J Clin Oncol 6: 163, and 6: 392, 1988.
24. Balch CM, Milton GW, Cascinelli N, Milton GW, Sim FH: Elective node dissection: Pros and cons. In: Balch CM, Houghton AN, Milton GW, Sober A, Soong S-j (eds): Cutaneous Melanoma, 2nd edition, p 345. Philadelphia. J B Lippincott, 1992.
25. Thompson JF, McCarthy WH, Robinson E et al: Sentinel lymph node biopsy in 102 patients with clinical stage I melanoma undergoing elective lymph node dissection. 47th Cancer Symposium, Society of Surgical Oncology, March 1994, Houston, TX (Abstract).
26. Krag DN, Meijer SJ, Weaver DL, Loggic BW, Harlow SP, Tanabe KK, Laughlin EH, alex JC: Minimal-access surgery for staging of malignant melanoma. Arch Surg 130: 654-8, 1995.
27. Veronesi U, et al: Distribution of axillary nodal metastases by level. Cancer 59: 682-687, 1987.
28. Reintgen DS: Melanoma nodal metastases; Biologic significance and therapeutic considerations. Surg Clin North Amer 5: 105-120, 1996.
29. Reintgen DS, Einstein A The role of research in cost containment. Cancer Control: Journal of the Moffitt Cancer Center 2: 429-431, 1995
30. Albertini JJ, Cruse CW, Rapaport D et al: Intraoperative radiolymphoscintigraphy improves sentinel node identification in melanoma patients. Ann Surg 223: 217-224, 1996.
31. Gershenwald J, Thompson W, Mansfield P, Lee J, Colome M, Balch C, Reintgen D, Ross M: Patterns of failure in melanoma patients after successful lymphatic mapping and negative sentinel node biopsy. Society of Surgical Oncology, 1996 (Abstract).
32. Multicenter Selective Lymphadenectomy Trial. National Cancer Institute Grant No. POI CA29605-12.
33. Kirkwood JM, Strawderman MH, Ernstoff MS, Smith TJ, Borden EC, Blum RH: Adjuvant therapy of high-risk resected cutaneous melanoma: The Eastern Cooperative Oncology Group Trial EST 1684. J Clin Oncol 14: 7-17, 1996.